Ghent University Academic Bibliography

Add to list

Journal Article
A1
open access

Drugging the NLRP3 inflammasome : from signalling mechanisms to therapeutic targets

Lieselotte Vande Walle (UGent) and Mohamed Lamkanfi (UGent)

(2024) NATURE REVIEWS DRUG DISCOVERY. 23(1). p.43-66

Add to list

Journal Article
A1
open access

The halogen bond in weakly bonded complexes and the consequences for aromaticity and spin-orbit coupling

Ana V. Cunha, Remco Havenith (UGent) , Jari van Gog, Freija De Vleeschouwer, Frank De Proft and Wouter Herrebout

(2023) MOLECULES. 28(2).

Add to list

Journal Article
A1
open access

Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine

Isabel Leroux-Roels (UGent) , Jacques Bruhwyler, Lilli Stergiou, Mark Sumeray, Jasper Joye, Cathy Maes, Paul-Henri Lambert and Geert Leroux-Roels (UGent)

(2023) VACCINES. 11(2).

Add to list

Journal Article
A1
open access

Development of diclofenac sodium 3D printed cylindrical and tubular-shaped tablets through hot melt extrusion and fused deposition modelling techniques

Tryfon Digkas (UGent) , Alina Porfire, Jeroen Van Renterghem, Aseel Samaro (UGent) , Gheorghe Borodi, Chris Vervaet (UGent) , Andrea Gabriela Crișan, Sonia Iurian, Thomas De Beer (UGent) and Ioan Tomuta

(2023) PHARMACEUTICALS. 16(8).

Add to list

Journal Article
A1
open access

Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma

Muhammad Rishfi (UGent) , Simon Krols (UGent) , Fien Martens (UGent) , Sarah-Lee Bekaert (UGent) , Ellen Sanders (UGent) , Aline Eggermont (UGent) , Fanny De Vloed (UGent) , Joshua Robert Goulding (UGent) , Martijn Risseeuw (UGent) , Jan Molenaar, et al.

(2023) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 247.

Add to list

Journal Article
A1
open access

Molecular pathways for polymer degradation during conventional processing, additive manufacturing, and mechanical recycling

Daniel Amaral Ceretti, Mariya Edeleva (UGent) , Ludwig Cardon (UGent) and Dagmar D'hooge (UGent)

(2023) MOLECULES. 28(5).

Add to list

In vitro and ex vivo models for assessing drug permeation across the cornea

Inès De Hoon, Rabah Boukherroub, Stefaan De Smedt (UGent) , Sabine Szunerits and Félix Sauvage (UGent)

(2023) MOLECULAR PHARMACEUTICS. 20(7). p.3298-3319

Add to list

Journal Article
A1
open access

Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives

Kris Cooreman, Bart De Spiegeleer (UGent) , Christof Van Poucke, David Vanavermaete, Daan Delbare, Evelien Wynendaele (UGent) and Bavo De Witte

(2023) ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY. 102.

Add to list

Journal Article
A1
open access

Retained chromosomal integrity following CRISPR-Cas9-based mutational correction in human embryos

Bieke Bekaert (UGent) , Annekatrien Boel (UGent) , Lisa De Witte (UGent) , Winter Vandenberghe (UGent) , Mina Popovic, Panagiotis Stamatiadis, Gwenny Cosemans (UGent) , Lise Tordeurs (UGent) , Athina-Maria De Loore, Susana Marina Chuva de Sousa Lopes (UGent) , et al.

(2023) MOLECULAR THERAPY. 31(8). p.2326-2341

Add to list

Journal Article
A1
open access

Congenital hydrocephalus : new Mendelian mutations and evidence for oligogenic inheritance

Valerie Jacquemin, Nassim Versbraegen, Sarah Duerinckx, Annick Massart, Julie Soblet, Camille Perazzolo, Nicolas Deconinck (UGent) , Elise Brischoux-Boucher, Anne De Leener, Nicole Revencu, et al.

(2023) HUMAN GENOMICS. 17(1).

Academic Bibliography

Drugging the NLRP3 inflammasome : from signalling mechanisms to therapeutic targets

The halogen bond in weakly bonded complexes and the consequences for aromaticity and spin-orbit coupling

Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine

Development of diclofenac sodium 3D printed cylindrical and tubular-shaped tablets through hot melt extrusion and fused deposition modelling techniques

Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma

Molecular pathways for polymer degradation during conventional processing, additive manufacturing, and mechanical recycling

In vitro and ex vivo models for assessing drug permeation across the cornea

Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives

Retained chromosomal integrity following CRISPR-Cas9-based mutational correction in human embryos

Congenital hydrocephalus : new Mendelian mutations and evidence for oligogenic inheritance

Contents

Support

Contact